Cancer of Kidney research hub

Cabo-POLARIS : A Trial to Evaluate Cabozantinib Among Haemodialysied Patients

This study looks at a new drug, cabozantinib, for kidney cancer patients who are on dialysis. It aims to understand if the treatment is safe and works well for them, as they are often not included in other trials.